| Expression pattern: |
DN |
| Associated gene: |
p21, CDK2, ID-1, E2F1, FAK, HIF1a |
| Associated microRNA: |
miR-149, miR-22, miR-136 |
| Biological function: |
Associated with CAD susceptibility via SNP-dependent reduction of circFOXO3 expression. |
| Molecular mechanism: |
A flanking-intron SNP (rs12196996) is associated with reduced circFOXO3 expression (suggesting altered back-splicing/formation) without affecting linear FOXO3 mRNA expression. |
| Biological pathway or process: |
not specified |
| Detected method: |
Q
|
| Validation methods: |
divergent primers PCR; Sanger Sequencing; RT-qPCR; Clinical Sample Validation; Cohort Study; Bioinformatics Analysis |
| Clinical significance: |
rs12196996 at circFOXO3 flanking intron is associated with CAD risk and links to decreased circFOXO3 expression; suggested as a biomarker for CAD risk assessment. |
| Description: |
This study links the flanking-intron SNP rs12196996 to reduced circFOXO3 expression in PBMCs and increased susceptibility to coronary artery disease in a Chinese Han case-control cohort. The variant appears to affect circFOXO3 formation/expression without altering linear FOXO3 levels, suggesting a circRNA-specific regulatory effect relevant to CAD risk. |
| Confidence score: |
0.6238 |